scispace - formally typeset
Open AccessJournal ArticleDOI

A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics.

TLDR
A reagent-agnostic automated SARS-CoV-2 testing platform that can be quickly deployed and scaled is presented and installed in NHS diagnostic labs, increasing testing capacity by 1000 samples per day.
Abstract
The SARS-CoV-2 pandemic has shown how a rapid rise in demand for patient and community sample testing can quickly overwhelm testing capability globally. With most diagnostic infrastructure dependent on specialized instruments, their exclusive reagent supplies quickly become bottlenecks, creating an urgent need for approaches to boost testing capacity. We address this challenge by refocusing the London Biofoundry onto the development of alternative testing pipelines. Here, we present a reagent-agnostic automated SARS-CoV-2 testing platform that can be quickly deployed and scaled. Using an in-house-generated, open-source, MS2-virus-like particle (VLP) SARS-CoV-2 standard, we validate RNA extraction and RT-qPCR workflows as well as two detection assays based on CRISPR-Cas13a and RT-loop-mediated isothermal amplification (RT-LAMP). In collaboration with an NHS diagnostic testing lab, we report the performance of the overall workflow and detection of SARS-CoV-2 in patient samples using RT-qPCR, CRISPR-Cas13a, and RT-LAMP. The validated RNA extraction and RT-qPCR platform has been installed in NHS diagnostic labs, increasing testing capacity by 1000 samples per day.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Simultaneous dual-gene diagnosis of SARS-CoV-2 based on CRISPR/Cas9-mediated lateral flow assay.

TL;DR: A CRISPR/Cas9-mediated triple-line lateral flow assay (TL-LFA) combined with multiplex reverse transcription-recombinase polymerase amplification (RT-RPA) for rapid and simultaneous dual-gene detection of SARS-CoV-2 in a single strip test is developed.
Journal ArticleDOI

CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.

TL;DR: In this paper, the authors discuss the advantages and limitations of these methods, and discuss how they can contribute to improving the efficiency of the current testing systems for combating SARS-CoV-2.
Journal ArticleDOI

A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores.

TL;DR: In this paper, the authors proposed an innovative method to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using isothermal amplification of nucleic acids on a mesh containing multiple microfluidic pores.
Journal ArticleDOI

Automation in the Life Science Research Laboratory.

TL;DR: Growing the range of automation options suitable for research laboratories will require more flexible, modular and cheaper designs, and academic and commercial developers of automation will increasingly need to design with an environmental awareness and an understanding that large high-tech robotic solutions may not be appropriate for laboratories with constrained financial and spatial resources.
Journal ArticleDOI

Vaccine delivery systems toward lymph nodes.

TL;DR: The design principles of lymph node targeting vaccine delivery based on the anatomy of lymph nodes and vaccine administration routes are first summarized and the challenges and opportunities of current delivery systems for vaccines are concluded.
References
More filters
Journal ArticleDOI

An interactive web-based dashboard to track COVID-19 in real time.

TL;DR: The outbreak of the 2019 novel coronavirus disease (COVID-19) has induced a considerable degree of fear, emotional stress and anxiety among individuals around the world.
Journal ArticleDOI

CRISPR-Cas12-based detection of SARS-CoV-2.

TL;DR: The CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT–PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.
Journal ArticleDOI

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

TL;DR: ShERLOCK as discussed by the authors is a platform that combines isothermal preamplification with Cas13 to detect single molecules of RNA or DNA, which can detect Dengue or Zika virus single-stranded RNA and mutations in patient liquid biopsy samples via lateral flow.
Related Papers (5)